QT
ONCT

Quantamental Technologies’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Quantamental Technologies’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5
Closed – – 1452
2019
Q3 		$0 Buy
+5
New +$512 ﹤0.01% 1894

Other funds holding ONCT

Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DY
Dowling & Yahnke San Diego, California $2.15B AUM 10.82% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantamental Technologies's ONCT Position: Q4 2019 in Review

Quantamental Technologies sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2019, closing a stake of 5 shares.

Quantamental Technologies first reported a position in ONCT in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 21 funds tracked by Wall St. Rank hold ONCT as of Q4 2019.

  • Quantamental Technologies reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 5 Oncternal Therapeutics, Inc. Common Stock shares in Q4 2019.
  • Quantamental Technologies first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Quantamental Technologies's Oncternal Therapeutics, Inc. Common Stock position peaked at $0 in Q3 2019.
  • 21 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.